News & Updates

2017-06-22
Satellite Meeting Diabetes in Greece-Under Poseidon’s eye

Following the Euromedlab 2017 in Athens a Satellite Meeting Diabetes took place in Sounio. The scientific program addressed innovations concerning both the laboratory and the clinic. 

Read more

2017-05-31
Successful inspection of DiaSys by German institution

The competent authority in charge of producer compliance with the German Medical Device Law (so‑called “Landesamt für Soziales, Jugend und Versorgung”) paid a control visit to DiaSys in May. The inspectors were given a company presentation and a tour round the premises and production facilities.

Read more

2017-05-17
JEOL pays visit to DiaSys

JEOL, supplier of BioMajesty®JCA BM6010/C analyzer maintains a long-term cooperation with DiaSys. In the fiscal year 2016, 38 devices were bought from JEOL. In total more than 60 BioMajesty® JCA BM6010/C were placed in Europe and Russia.

Read more

2017-05-08
EgypMedica Exhibition in Egypt

EgypMedica Exhibition was held in the first week of May 2017 in Cairo. Laptop, DiaSys’ Egyptian distributor, represented by Dr. Helmy Fouad and DiaSys’ Area Business Director Christophe Bayet had a 36 m2 booth in an excellent location just in front of the conference hall.

Read more

2017-04-24
First DiaSys Total Laboratory Automation (TLA) solution running in routine!

In January 2017 the redesign of the TLA in the institute for biochemistry of the hospital in Svitavy in Czech Republic started. The redesign of the existing TLA was done by a step by step exchange of the installed KONE 60 devices by BioMajesty®JCA-BM6010/C.

Read more

2017-04-19
Cystatin C FS – The New Immunoturbidimetric Gold Standard

DiaSys achieved excellent results in a recent multicenter study for Cystatin C FS and succeeded with major advantages over its competitors.
Read more

2017-01-18
Tosoh and DiaSys Announce Collaboration

Tosoh and DiaSys join forces to offer a fast, precise and sensitive high quality solution for clinical laboratory testing.
Read more

2016-10-28
QDx Lipidcheck™

Complete POC Lipid Profile

  • One sample: 6 parameters –Total cholesterol, triglycerides, HDL, LDL, HDL/ LDL ratio and TC/HDL ratio
  • Easy to handle
  • Only 45μL capillary/venous blood
  • Fast, easy 3-step procedure
  • Factory calibrated test strips
  • Small, lightweight design for versatility and portability
  • Memory 1000 tests 

QDx LipidcheckTM offers a convenient, accurate and cost effective point of care lipid profile tests. It serves as a diagnostic tool that provides information for immediate risk assessment and therapeutic monitoring of heart disease, whether in the physician’s office, clinic, hospital or other practice settings.

2016-10-18
QDx Allerg™

  • Point of care allergy testing
  • Results within 30 minutes
  • 2 drops of whole blood required

QDx Allerg™ is a Point of Care semi-quantitative test for testing inhalant and food (veg and non-veg) allergies. It performs comprehensive in vitro testing for around 20 allergen specific IgE antibodies (including mixes) simultaneously. The test requires only 100 µL of whole blood from a finger prick and giving results within 30 minutes. For further information please visit our pages concerning QDx Allerg™

2016-08-08
Early detection of Dengue and Malaria with DiaSys QDx

Malaria and Dengue fever are mosquito borne diseases that have the possibility to become pandemic on certain continents. DiaSys offers rapid diagnostic tests for the diagnosis of malaria and dengue fever within our QDx POCT product portfolio. For malaria we offer 2 kits, QDx Malaria PAN/Pf and QDx Malaria Pv/Pf both of which are 2 step assays with results in 15 minutes and requiring only 5 µL of whole blood. Both kits can detect down to 50 parasites per µL whole blood this being a great advantage with rapid diagnostic tests. For Dengue fever we offer QDx Dengue Combo, a rapid and qualitative test for the detection of Dengue IgG, IgM antibodies and Dengue NS1 antigen in human whole blood, serum or plasma. This can detect infection from day 1 with results in 15 minutes.
For further information please visit our pages concerning QDx POCT.